NCT06703892
- Conditions
- Diffuse Large B Cell Lymphoma Refractory, Diffuse Large B Cell Lymphoma Relapsed, Follicular Lymphoma ( FL), +13 more
- Locations
-
- National Taiwan University Hospital Taipei, Taiwan
Clinical trial condition
Primary Mediastinal Large B-Cell Lymphoma-Refractory
Explore clinical trials studying Primary Mediastinal Large B-Cell Lymphoma-Refractory. Study availability and eligibility vary by location and protocol.
2 public trials
2 recruiting studies
Primary Mediastinal Large B-Cell Lymphoma-Refractory trial results
NCT06209619
- Conditions
- B-Cell Non-Hodgkin Lymphoma-Recurrent, B-Cell Non-Hodgkin Lymphoma-Refractory, Diffuse Large B-Cell Lymphoma-Recurrent, +9 more
- Locations
-
- Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
Related conditions
- Primary Mediastinal Large B-Cell Lymphoma-Recurrent (2)
- B-Cell Non-Hodgkin Lymphoma-Recurrent (1)
- B-Cell Non-Hodgkin Lymphoma-Refractory (1)
- Diffuse Large B Cell Lymphoma Refractory (1)
- Diffuse Large B Cell Lymphoma Relapsed (1)
- Diffuse Large B-Cell Lymphoma-Recurrent (1)
- Diffuse Large B-Cell Lymphoma-Refractory (1)
- Follicular Lymphoma ( FL) (1)